Your browser doesn't support javascript.
loading
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
Bornschein, Jan; Wernisch, Lorenz; Secrier, Maria; Miremadi, Ahmad; Perner, Juliane; MacRae, Shona; O'Donovan, Maria; Newton, Richard; Menon, Suraj; Bower, Lawrence; Eldridge, Matthew D; Devonshire, Ginny; Cheah, Calvin; Turkington, Richard; Hardwick, Richard H; Selgrad, Michael; Venerito, Marino; Malfertheiner, Peter; Fitzgerald, Rebecca C.
Afiliación
  • Bornschein J; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Wernisch L; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany.
  • Secrier M; Translational Gastroenterology Unit, Oxford University Hospitals, Oxford, United Kingdom.
  • Miremadi A; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Perner J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • MacRae S; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.
  • O'Donovan M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Newton R; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Menon S; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Bower L; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Eldridge MD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Devonshire G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Cheah C; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Turkington R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Hardwick RH; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Selgrad M; Department of Oncology, Queen's University, Northern Ireland, United Kingdom.
  • Venerito M; Department of Surgery, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Malfertheiner P; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany.
  • Fitzgerald RC; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany.
Int J Cancer ; 145(12): 3389-3401, 2019 12 15.
Article en En | MEDLINE | ID: mdl-31050820
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Unión Esofagogástrica / Transcriptoma Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Unión Esofagogástrica / Transcriptoma Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article